Comparison the Effects of 3 Different Intraarticular Ketamine Doses on Postoperative Pain.
NCT ID: NCT03955809
Last Updated: 2020-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
75 participants
INTERVENTIONAL
2013-08-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Three Different Doses of Intrathecal Ketamine
NCT05074823
Analgesic Effect of Intraoperative Intravenous S-Ketamine During Total Knee Arthroplasty Surgery
NCT05289050
Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery
NCT03248648
Post-op Ketamine Study
NCT03865550
Esketamine vs. Ketorolac for Prevention of Postoperative Pain and Cognitive Dysfunction After Total Knee Arthroplasty
NCT05132595
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group KL1: 0.5 mg/kg ketamin in % 0..9 NaCl at a total volume of 20 ml Group KL2: 1 mg/kg ketamin in % 0.9 NaCl at a total volume of 20 ml Group SL: 20 ml % 0.9 NaCl ll patients are going to receive a periarticula injection of 10 ml 0.5 bupivacaine and patient controlled analgesia with morphine.
VAS scores and total analgesic requirement is going to be evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketamine 0.5 mg/kg
ketamin 0.5 mg/kg intraarticular
Ketamine 0.5
İntrarticular Ketamine 0.5 mg/kg + 0.9 Nacl Total Volume 20 ml
Ketamine 1 mg/kg
ketamin 1 mg/kg intraarticular injection
Ketamine 1
İntrarticular Ketamine 1 mg/kg + 0.9 NaCl Total Volume 20 ml
% 0.9 Saline
% 0.9 NaCL intraarticular injection
% 0.9 NaCl
Intraarticular %0.9 NaCl
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketamine 0.5
İntrarticular Ketamine 0.5 mg/kg + 0.9 Nacl Total Volume 20 ml
Ketamine 1
İntrarticular Ketamine 1 mg/kg + 0.9 NaCl Total Volume 20 ml
% 0.9 NaCl
Intraarticular %0.9 NaCl
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-II
Exclusion Criteria
* Travmatic knee injury
* Long ter analgesic use
* Intraartiular catheter insertion at the end of surgery
18 Years
75 Years
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Balikesir University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozlem Sagir, MD
Associated Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
osagir3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.